We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jun 2023
  • Code : CMI3784
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Global wound debridement products market is estimated to be valued at US$ 779.9 million in 2023 and is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030).

Analysts’ Views on Global Wound Debridement Products Market:

Global wound debridement products market growth can be hindered by lack of awareness about the wound debridement management. For instance, in January, 2022, Scapa Healthcare, a U.S.-based wound dressing company, signed an exclusive technology licensing agreement with Synedgen Inc., a U.S.-based medical technology company, for novel wound care technology. Under the terms of this agreement, Scapa Healthcare will have exclusive rights over Synedgen Inc.’s glycopolymer technology in the field of dermal wounds and surgical care applications both over the counter and in the professional setting.

Figure 1. Global Wound Debridement Products Market Share (%), By Product Type, 2023

WOUND DEBRIDEMENT PRODUCTS MARKET

To learn more about this report, request a free sample copy

Global Wound Debridement Products Market – Drivers

Increasing Collaborations among Key Market Players

Increasing adoption of inorganic strategies such as collaborations among key market players is expected to drive the global wound debridement products market over the forecast period. For instance, on March 8, 2023, Ceapro Inc., a Canada-based biotechnology company, announced that its study in collaboration with The Angiogenesis Foundation, non-profit organization in U.S., on Avena Sativa derived therapeutics β-Glucan and Avenanthramide was accepted for presentation at annual meeting of wound healing society held at Canada. It was found that oats (Avena Sativa) can accelerate wound healing in mice by anti-inflammatory mechanisms, and can reduce scar formation. It can stimulate angiogenesis.

Increasing Awarenss Programs by Key Market Players

In June 2021, Sanara MedTech Inc., a U.S.-based surgical and chronic wound care product provider company, announced a partnership with Pixalere Healthcare Inc., a Canada-based wound care software company, to advance its comprehensive wound and skin care strategy. The aim of this partnership is to use Pixalere’s technology including decision support, documentation, and wound tracking analytics, with complementary Sanara solutions that offer virtual access to expert wound and skin physicians, advanced diagnostics, and wound care product order fulfillment.

Figure 2. Global Wound Debridement Products Market Value (US$ Million), By Region, 2023

WOUND DEBRIDEMENT PRODUCTS MARKET

To learn more about this report, request a free sample copy

Global Wound Debridement Products Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global wound debridement products market over the forecast period. North America holds 56.5% of the market share over the forecast period due to increasing number of geriatric populationand  increasing prevalence of diabetes . According to report spublished by the U.S. Centers for Disease Control & Prevention, on June 29, 2022, 37.3 million people in the U.S. had diabetes that is 11.3% of the total the U.S. population in 2021. Out of these, only 28.7 million people are diagnosed while 8.5 million cases were not even diagnosed thatis equivalent to 23.0% of adults. Cases of diabetic foot ulcers is present in total 2.4% of hospitalized patients. Overall rate of mortality is 13% and the incidences of limb amputation is nearly 25%.

Wound Debridement Products Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 779.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 9.2% 2030 Value Projection: US$ 1,446.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices, Surgical Wound Debridement Devices, Mechanical Debridement Pads, Traditional Wound Debridement Devices
  • By Application: Chronic Ulcers, Surgical Wounds, Traumatic Wounds, Burn Cases
  • By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Others (Nursing Facilities, etc.)
Companies covered:

DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, Human Biosciences Inc.

Growth Drivers:
  • Increasing collaborations among key market players
  • Increasing awareness programs by key market players   
Restraints & Challenges:
  • High cost associated with wound care management

Global Wound Debridement Products Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems reagrding transportation of drugs from one place to another.

However, the COVID-19 pandemic had negative impact on the global debridement products market. For instance, according to data publsihed by the commonwealth fund on May 19, 2020, the number of patient visits to hospitals and ambulatory practices declined nearly 60% by the beginning of pandemic in April 2020. Even after pandemic, number of visits were roughly one third lower than what was before the pandemic.

Global Wound Debridement Products Market- Segmentation

Global wound debridement products market report is segmented into product type, application, end user, and region.

Based on Product Type, the market is segmented into hydrosurgical debridement devices, low frequency ultrasound devices, surgical wound debridement devices, mechanical debridement pads, traditional wound debridement devices, and larval therapy. Out of which, the low frequency ultrasound devices segment is expected to hold a dominant position in the global wound debridement products market during the forecast period due to increasing demand of ultrasound devices for wound debridement management.

Based on Application, the market is segmented into chronic ulcers, surgical wounds, traumatic wounds, and burn cases. Out of which, chronic ulcers segment is expected to hold a dominant position in the global wound debridement products market during the forecast period due to increasing prevalence of chronic ulcers among patients.

Based on End User, the market is segmented into hospitals, ambulatory surgical centers, specialized clinics, and others (nursing facilities, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing number of hospitals.

Based on Region, North America is to hold a dominant position in the global wound debridement products market during the forecast period due to increasing demand of wound debridement products in that region.

Among all segmentation, the product type segment has the highest potential due to increasing use of debridement products for the wound care managemnt

Global Wound Debridement Products Market- Cross Sectional Analysis

Among all the segments, surgical wound debridement devices hold dominat position in the global wound debridement products market. Thus, increasing numbers of geriatric patients, increasing cases of injuries and trauma and increasing product launches by key market players in different regions are expected to drive the market growth. For instance, in September, 2021, Human Biosciences Inc., a U.S. based biotechnology company, launched two wound care management products called Medifil and Skin Temp. These products helps to stop bleeding, and plays an important role in healing of wound.

Global Wound Debridement Products Market: Key Developments

  • On April 8, 2021, Healogics LLC, a U.S.-based advanced wound care provider company, launched healing awareness program on foot health called ‘The Healogics Foot Health campaign’ to prevent chronic wounds. In this program, people were made aware regarding need for regular foot screening to detect non-healing wounds. The team reached out to healthcare providers to encourage foot screening and provide patient focused educational resources. The program is dedicated to empower both patients and healthcare providers with resources to help improve health, heal wounds and prevent amputations.
  • Global Wound Debridement Products Market: Key Trends

Increasing Awareness Campaign by Local Health Department To Raise Awareness For Wound Care Management

Increasing awareness campaign by local health department to raise awareness for wound care management is expected to drive the market growth over the forecast period. For instance, in August 2022, The Far West Local Health District (LHD), the local health department, organized wound awareness week to raise awareness in the community of the impact of wounds and to improve awareness of chronic wounds and influence wound management policy.

Global Wound Debridement Products Market: Restraint

High Cost Associated With Wound Care Management

The high cost associated with wound care management with advanced wound dressing material, wound care devices, and bioactive products is expected to hinder the market growth over the forecast period. For instance, according to article published by International Wound Journal, in June 2020, the gross healthcare cost per patient ranges from US$ 15,789 –US$ 17,761. This adds the cost of surgical dressings that are required to change every day. Apart from this, the treatment formulation suggested by healthcare practitioner also adds up the cost. Depending on duration of treatment the cost increases.

Global Wound Debridement Products Market - Key Players

Major players operating in the global wound debridement products market include DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, and Human Biosciences Inc.

Definition: Wound debridement is the process of removing dead tissue from wounds. It is necessary to accelerate healing process of the remaining healthy tissue. Biological debridement, enzymatic debridement, autolytic debridement, and mechanical debridement are some of the types of wound debridement. Hydrotherapy, wet-to-dry dressing, and monofilament debridement pads are the types of mechanical debridement.

Frequently Asked Questions

The global wound debridement products market is estimated to be valued at US$ 779.9 million in 2023 and is expected to exhibit a CAGR of 9.2% between 2023 and 2030.

Increasing collaborations and awareness programs by key market players is expected to drive the market growth.

Low Frequency Ultrasound Devices is the leading product type segment in the market.

High cost associated with wound care management is expected to hinder the market growth over the forecast period.

Major players operating in the market include DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, Human Biosciences Inc.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo